Neuroscience Antibodies & Assays Market 2027 By Product, Technology, Application, End User and Geography | The Insight Partners

Neuroscience Antibodies & Assays Market to 2027 - Global Analysis and Forecasts By Product (Consumables, Instruments); Technology (Molecular Diagnostics, Clinical Chemistry, Immunoassays/Immunochemistry, Others); Application (in Vitro Diagnostics, Research, Drug Discovery); End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) and Geography

Report Code: TIPBT00002234 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Neuroscience involves the study of nervous system, where the research is completely relies on assays and antibodies. These antibodies and assays are specific that helps to identify and examine reactions on the cellular, biochemical and molecular level. Antibody-based approaches are used for the localization, isolation and characterization of targeted proteins that majorly used in the cellular and molecular neuroscience. On the other hand, the use of assays provide an efficient, valuable solution for determination of critical targets that are involved in synaptic signaling, neural development and neurodegeneration.

MARKET DYNAMICS

The global neuroscience antibodies & assays market is anticipated to grow with a significant rate in the coming years, owing to the increasing incidence of neurological disorders, growing pharmaceutical & biotechnology industries and increasing investments in neuroscience research. On the other hand, increasing research & development activities are projected to offer novel growth opportunities for the players operating in the neuroscience antibodies & assays market, in the coming years

MARKET SCOPE

The "Global Neuroscience Antibodies & Assays Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of neuroscience antibodies & assays market with detailed market segmentation by product, technology, application, end user and geography. The global neuroscience antibodies & assays market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading neuroscience antibodies & assays market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global neuroscience antibodies & assays market is segmented on the basis of product, technology, application and end user. Based on product, the market is segmented as consumables and instruments. On the basis of technology, the global neuroscience antibodies & assays market is segmented into molecular diagnostics, clinical chemistry, immunoassays/immunochemistry and others. Based on application, the market is segmented as in vitro diagnostics, research and drug discovery. Based on end user, the market is segmented as hospitals & diagnostics centers, academic & research institutes and pharmaceutical & biotechnology companies.
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuroscience antibodies & assays market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuroscience antibodies & assays market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting neuroscience antibodies & assays market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neuroscience antibodies & assays market in these regions.
MARKET PLAYERS

The reports cover key developments in the neuroscience antibodies & assays market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from neuroscience antibodies & assays market are anticipated to lucrative growth opportunities in the future with the rising demand for neuroscience antibodies & assays in the global market. Below mentioned is the list of few companies engaged in the neuroscience antibodies & assays market

The report also includes the profiles of key neuroscience antibodies & assays market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  F. Hoffmann-La Roche Ltd.
  •  Thermo Fisher Scientific Inc.
  •  Merck KGaA
  •  Bio-Rad Laboratories, Inc.
  •  Siemens
  •  GenScript
  •  Cell Signaling Technology, Inc.
  •  Santa Cruz Biotechnology, Inc.
  •  BioLegend, Inc.
  •  Abcam plc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Neuroscience Antibodies & Assays Market - By Product
 1.3.2 Neuroscience Antibodies & Assays Market - By Technology
 1.3.3 Neuroscience Antibodies & Assays Market - By Application
 1.3.4 Neuroscience Antibodies & Assays Market - By End User
 1.3.5 Neuroscience Antibodies & Assays Market - By Region
 1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET - GLOBAL MARKET ANALYSIS
 6.1. NEUROSCIENCE ANTIBODIES AND ASSAYS - GLOBAL MARKET OVERVIEW
 6.2. NEUROSCIENCE ANTIBODIES AND ASSAYS - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE
7. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
 7.1. OVERVIEW
 7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
 7.3. CONSUMABLES
 7.3.1. Overview
 7.3.2. Consumables Market Forecast and Analysis
 7.3.3. Antibodies Market
 7.3.3.1. Overview
 7.3.3.2. Antibodies Market Forecast and Analysis
 7.3.4. Reagents Market
 7.3.4.1. Overview
 7.3.4.2. Reagents Market Forecast and Analysis
 7.3.5. Assays Kits Market
 7.3.5.1. Overview
 7.3.5.2. Assays Kits Market Forecast and Analysis
 7.4. INSTRUMENTS
 7.4.1. Overview
 7.4.2. Instruments Market Forecast and Analysis
 7.4.3. Microplates Readers Market
 7.4.3.1. Overview
 7.4.3.2. Microplates Readers Market Forecast and Analysis
 7.4.4. Immunoassay Analyzers Market
 7.4.4.1. Overview
 7.4.4.2. Immunoassay Analyzers Market Forecast and Analysis
 7.4.5. Others. Market
 7.4.5.1. Overview
 7.4.5.2. Others. Market Forecast and Analysis
8. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
 8.1. OVERVIEW
 8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
 8.3. MOLECULAR DIAGNOSTICS
 8.3.1. Overview
 8.3.2. Molecular Diagnostics Market Forecast and Analysis
 8.4. CLINICAL CHEMISTRY
 8.4.1. Overview
 8.4.2. Clinical Chemistry Market Forecast and Analysis
 8.5. IMMUNOASSAYS/IMMUNOCHEMISTRY
 8.5.1. Overview
 8.5.2. Immunoassays/Immunochemistry Market Forecast and Analysis
 8.6. OTHERS
 8.6.1. Overview
 8.6.2. Others Market Forecast and Analysis
9. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
 9.1. OVERVIEW
 9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
 9.3. IN VITRO DIAGNOSTICS
 9.3.1. Overview
 9.3.2. In Vitro Diagnostics Market Forecast and Analysis
 9.4. RESEARCH
 9.4.1. Overview
 9.4.2. Research Market Forecast and Analysis
 9.5. DRUG DISCOVERY
 9.5.1. Overview
 9.5.2. Drug Discovery Market Forecast and Analysis
10. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
 10.1. OVERVIEW
 10.2. END USER MARKET FORECASTS AND ANALYSIS
 10.3. HOSPITALS & DIAGNOSTICS CENTERS
 10.3.1. Overview
 10.3.2. Hospitals & Diagnostics Centers Market Forecast and Analysis
 10.4. ACADEMIC & RESEARCH INSTITUTES
 10.4.1. Overview
 10.4.2. Academic & Research Institutes Market Forecast and Analysis
 10.5. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES.
 10.5.1. Overview
 10.5.2. Pharmaceutical & Biotechnology Companies. Market Forecast and Analysis
11. NEUROSCIENCE ANTIBODIES & ASSAYS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 11.1. NORTH AMERICA
 11.1.1 North America Neuroscience Antibodies & Assays Market Overview
 11.1.2 North America Neuroscience Antibodies & Assays Market Forecasts and Analysis
 11.1.3 North America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Product
 11.1.4 North America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Technology
 11.1.5 North America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Application
 11.1.6 North America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By End User
 11.1.7 North America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Countries
 11.1.7.1 United States Neuroscience Antibodies & Assays Market
 11.1.7.1.1 United States Neuroscience Antibodies & Assays Market by Product
 11.1.7.1.2 United States Neuroscience Antibodies & Assays Market by Technology
 11.1.7.1.3 United States Neuroscience Antibodies & Assays Market by Application
 11.1.7.1.4 United States Neuroscience Antibodies & Assays Market by End User
 11.1.7.2 Canada Neuroscience Antibodies & Assays Market
 11.1.7.2.1 Canada Neuroscience Antibodies & Assays Market by Product
 11.1.7.2.2 Canada Neuroscience Antibodies & Assays Market by Technology
 11.1.7.2.3 Canada Neuroscience Antibodies & Assays Market by Application
 11.1.7.2.4 Canada Neuroscience Antibodies & Assays Market by End User
 11.1.7.3 Mexico Neuroscience Antibodies & Assays Market
 11.1.7.3.1 Mexico Neuroscience Antibodies & Assays Market by Product
 11.1.7.3.2 Mexico Neuroscience Antibodies & Assays Market by Technology
 11.1.7.3.3 Mexico Neuroscience Antibodies & Assays Market by Application
 11.1.7.3.4 Mexico Neuroscience Antibodies & Assays Market by End User
 11.2. EUROPE
 11.2.1 Europe Neuroscience Antibodies & Assays Market Overview
 11.2.2 Europe Neuroscience Antibodies & Assays Market Forecasts and Analysis
 11.2.3 Europe Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Product
 11.2.4 Europe Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Technology
 11.2.5 Europe Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Application
 11.2.6 Europe Neuroscience Antibodies & Assays Market Forecasts and Analysis - By End User
 11.2.7 Europe Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Countries
 11.2.7.1 Germany Neuroscience Antibodies & Assays Market
 11.2.7.1.1 Germany Neuroscience Antibodies & Assays Market by Product
 11.2.7.1.2 Germany Neuroscience Antibodies & Assays Market by Technology
 11.2.7.1.3 Germany Neuroscience Antibodies & Assays Market by Application
 11.2.7.1.4 Germany Neuroscience Antibodies & Assays Market by End User
 11.2.7.2 France Neuroscience Antibodies & Assays Market
 11.2.7.2.1 France Neuroscience Antibodies & Assays Market by Product
 11.2.7.2.2 France Neuroscience Antibodies & Assays Market by Technology
 11.2.7.2.3 France Neuroscience Antibodies & Assays Market by Application
 11.2.7.2.4 France Neuroscience Antibodies & Assays Market by End User
 11.2.7.3 Italy Neuroscience Antibodies & Assays Market
 11.2.7.3.1 Italy Neuroscience Antibodies & Assays Market by Product
 11.2.7.3.2 Italy Neuroscience Antibodies & Assays Market by Technology
 11.2.7.3.3 Italy Neuroscience Antibodies & Assays Market by Application
 11.2.7.3.4 Italy Neuroscience Antibodies & Assays Market by End User
 11.2.7.4 Spain Neuroscience Antibodies & Assays Market
 11.2.7.4.1 Spain Neuroscience Antibodies & Assays Market by Product
 11.2.7.4.2 Spain Neuroscience Antibodies & Assays Market by Technology
 11.2.7.4.3 Spain Neuroscience Antibodies & Assays Market by Application
 11.2.7.4.4 Spain Neuroscience Antibodies & Assays Market by End User
 11.2.7.5 United Kingdom Neuroscience Antibodies & Assays Market
 11.2.7.5.1 United Kingdom Neuroscience Antibodies & Assays Market by Product
 11.2.7.5.2 United Kingdom Neuroscience Antibodies & Assays Market by Technology
 11.2.7.5.3 United Kingdom Neuroscience Antibodies & Assays Market by Application
 11.2.7.5.4 United Kingdom Neuroscience Antibodies & Assays Market by End User
 11.3. ASIA-PACIFIC
 11.3.1 Asia-Pacific Neuroscience Antibodies & Assays Market Overview
 11.3.2 Asia-Pacific Neuroscience Antibodies & Assays Market Forecasts and Analysis
 11.3.3 Asia-Pacific Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Product
 11.3.4 Asia-Pacific Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Technology
 11.3.5 Asia-Pacific Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Application
 11.3.6 Asia-Pacific Neuroscience Antibodies & Assays Market Forecasts and Analysis - By End User
 11.3.7 Asia-Pacific Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Countries
 11.3.7.1 Australia Neuroscience Antibodies & Assays Market
 11.3.7.1.1 Australia Neuroscience Antibodies & Assays Market by Product
 11.3.7.1.2 Australia Neuroscience Antibodies & Assays Market by Technology
 11.3.7.1.3 Australia Neuroscience Antibodies & Assays Market by Application
 11.3.7.1.4 Australia Neuroscience Antibodies & Assays Market by End User
 11.3.7.2 China Neuroscience Antibodies & Assays Market
 11.3.7.2.1 China Neuroscience Antibodies & Assays Market by Product
 11.3.7.2.2 China Neuroscience Antibodies & Assays Market by Technology
 11.3.7.2.3 China Neuroscience Antibodies & Assays Market by Application
 11.3.7.2.4 China Neuroscience Antibodies & Assays Market by End User
 11.3.7.3 India Neuroscience Antibodies & Assays Market
 11.3.7.3.1 India Neuroscience Antibodies & Assays Market by Product
 11.3.7.3.2 India Neuroscience Antibodies & Assays Market by Technology
 11.3.7.3.3 India Neuroscience Antibodies & Assays Market by Application
 11.3.7.3.4 India Neuroscience Antibodies & Assays Market by End User
 11.3.7.4 Japan Neuroscience Antibodies & Assays Market
 11.3.7.4.1 Japan Neuroscience Antibodies & Assays Market by Product
 11.3.7.4.2 Japan Neuroscience Antibodies & Assays Market by Technology
 11.3.7.4.3 Japan Neuroscience Antibodies & Assays Market by Application
 11.3.7.4.4 Japan Neuroscience Antibodies & Assays Market by End User
 11.3.7.5 South Korea Neuroscience Antibodies & Assays Market
 11.3.7.5.1 South Korea Neuroscience Antibodies & Assays Market by Product
 11.3.7.5.2 South Korea Neuroscience Antibodies & Assays Market by Technology
 11.3.7.5.3 South Korea Neuroscience Antibodies & Assays Market by Application
 11.3.7.5.4 South Korea Neuroscience Antibodies & Assays Market by End User
 11.4. MIDDLE EAST AND AFRICA
 11.4.1 Middle East and Africa Neuroscience Antibodies & Assays Market Overview
 11.4.2 Middle East and Africa Neuroscience Antibodies & Assays Market Forecasts and Analysis
 11.4.3 Middle East and Africa Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Product
 11.4.4 Middle East and Africa Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Technology
 11.4.5 Middle East and Africa Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Application
 11.4.6 Middle East and Africa Neuroscience Antibodies & Assays Market Forecasts and Analysis - By End User
 11.4.7 Middle East and Africa Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Countries
 11.4.7.1 South Africa Neuroscience Antibodies & Assays Market
 11.4.7.1.1 South Africa Neuroscience Antibodies & Assays Market by Product
 11.4.7.1.2 South Africa Neuroscience Antibodies & Assays Market by Technology
 11.4.7.1.3 South Africa Neuroscience Antibodies & Assays Market by Application
 11.4.7.1.4 South Africa Neuroscience Antibodies & Assays Market by End User
 11.4.7.2 Saudi Arabia Neuroscience Antibodies & Assays Market
 11.4.7.2.1 Saudi Arabia Neuroscience Antibodies & Assays Market by Product
 11.4.7.2.2 Saudi Arabia Neuroscience Antibodies & Assays Market by Technology
 11.4.7.2.3 Saudi Arabia Neuroscience Antibodies & Assays Market by Application
 11.4.7.2.4 Saudi Arabia Neuroscience Antibodies & Assays Market by End User
 11.4.7.3 U.A.E Neuroscience Antibodies & Assays Market
 11.4.7.3.1 U.A.E Neuroscience Antibodies & Assays Market by Product
 11.4.7.3.2 U.A.E Neuroscience Antibodies & Assays Market by Technology
 11.4.7.3.3 U.A.E Neuroscience Antibodies & Assays Market by Application
 11.4.7.3.4 U.A.E Neuroscience Antibodies & Assays Market by End User
 11.5. SOUTH AND CENTRAL AMERICA
 11.5.1 South and Central America Neuroscience Antibodies & Assays Market Overview
 11.5.2 South and Central America Neuroscience Antibodies & Assays Market Forecasts and Analysis
 11.5.3 South and Central America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Product
 11.5.4 South and Central America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Technology
 11.5.5 South and Central America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Application
 11.5.6 South and Central America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By End User
 11.5.7 South and Central America Neuroscience Antibodies & Assays Market Forecasts and Analysis - By Countries
 11.5.7.1 Brazil Neuroscience Antibodies & Assays Market
 11.5.7.1.1 Brazil Neuroscience Antibodies & Assays Market by Product
 11.5.7.1.2 Brazil Neuroscience Antibodies & Assays Market by Technology
 11.5.7.1.3 Brazil Neuroscience Antibodies & Assays Market by Application
 11.5.7.1.4 Brazil Neuroscience Antibodies & Assays Market by End User
 11.5.7.2 Argentina Neuroscience Antibodies & Assays Market
 11.5.7.2.1 Argentina Neuroscience Antibodies & Assays Market by Product
 11.5.7.2.2 Argentina Neuroscience Antibodies & Assays Market by Technology
 11.5.7.2.3 Argentina Neuroscience Antibodies & Assays Market by Application
 11.5.7.2.4 Argentina Neuroscience Antibodies & Assays Market by End User
12. INDUSTRY LANDSCAPE
 12.1. MERGERS AND ACQUISITIONS
 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 12.3. NEW PRODUCT LAUNCHES
 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, KEY COMPANY PROFILES
 13.1. F. HOFFMANN-LA ROCHE LTD.
 13.1.1. Key Facts
 13.1.2. Business Description
 13.1.3. Products and Services
 13.1.4. Financial Overview
 13.1.5. SWOT Analysis
 13.1.6. Key Developments
 13.2. THERMO FISHER SCIENTIFIC INC.
 13.2.1. Key Facts
 13.2.2. Business Description
 13.2.3. Products and Services
 13.2.4. Financial Overview
 13.2.5. SWOT Analysis
 13.2.6. Key Developments
 13.3. MERCK KGAA
 13.3.1. Key Facts
 13.3.2. Business Description
 13.3.3. Products and Services
 13.3.4. Financial Overview
 13.3.5. SWOT Analysis
 13.3.6. Key Developments
 13.4. BIO-RAD LABORATORIES, INC.
 13.4.1. Key Facts
 13.4.2. Business Description
 13.4.3. Products and Services
 13.4.4. Financial Overview
 13.4.5. SWOT Analysis
 13.4.6. Key Developments
 13.5. SIEMENS
 13.5.1. Key Facts
 13.5.2. Business Description
 13.5.3. Products and Services
 13.5.4. Financial Overview
 13.5.5. SWOT Analysis
 13.5.6. Key Developments
 13.6. GENSCRIPT
 13.6.1. Key Facts
 13.6.2. Business Description
 13.6.3. Products and Services
 13.6.4. Financial Overview
 13.6.5. SWOT Analysis
 13.6.6. Key Developments
 13.7. CELL SIGNALING TECHNOLOGY, INC.
 13.7.1. Key Facts
 13.7.2. Business Description
 13.7.3. Products and Services
 13.7.4. Financial Overview
 13.7.5. SWOT Analysis
 13.7.6. Key Developments
 13.8. SANTA CRUZ BIOTECHNOLOGY, INC.
 13.8.1. Key Facts
 13.8.2. Business Description
 13.8.3. Products and Services
 13.8.4. Financial Overview
 13.8.5. SWOT Analysis
 13.8.6. Key Developments
 13.9. BIOLEGEND, INC.
 13.9.1. Key Facts
 13.9.2. Business Description
 13.9.3. Products and Services
 13.9.4. Financial Overview
 13.9.5. SWOT Analysis
 13.9.6. Key Developments
 13.10. ABCAM PLC.
 13.10.1. Key Facts
 13.10.2. Business Description
 13.10.3. Products and Services
 13.10.4. Financial Overview
 13.10.5. SWOT Analysis
 13.10.6. Key Developments
14. APPENDIX
 14.1. ABOUT THE INSIGHT PARTNERS
 14.2. GLOSSARY OF TERMS

 

The List of Companies

1. F. Hoffmann-La Roche Ltd.
2. Thermo Fisher Scientific Inc.
3. Merck KGaA
4. Bio-Rad Laboratories, Inc.
5. Siemens
6. GenScript
7. Cell Signaling Technology, Inc.
8. Santa Cruz Biotechnology, Inc.
9. BioLegend, Inc.
10. Abcam plc.